Preclinical Evaluation of Liposomal C8 Ceramide as a Potent Anti-Hepatocellular Carcinoma Agent

PLoS ONE - United States
doi 10.1371/journal.pone.0145195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Synthesis and Preclinical Validation of Novel P2Y1 Receptor Ligands as a Potent Anti-Prostate Cancer Agent

Scientific Reports
Multidisciplinary
2019English

Preclinical Verification of the Efficacy by Targeting Peptide-Linked Liposomal Nanoparticles for Hepatocellular Carcinoma Therapy

Nanobiomedicine
BiotechnologyBiomedical Engineering
2019English

A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer

Science Translational Medicine
Medicine
2012English

Evaluation of Uttroside B, a Saponin From Solanum Nigrum Linn, as a Promising Chemotherapeutic Agent Against Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2016English

Biological Activities of Fusarochromanone: A Potent Anti-Cancer Agent

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2014English

Preparation and Preclinical Evaluation of a Novel Liposomal Complete-Core Lipopolysaccharide Vaccine

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2000English

Preclinical Evaluation of Antitumor Activity of the Proteasome Inhibitor MLN2238 (Ixazomib) in Hepatocellular Carcinoma Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

LINCS L1000 Dataset-Based Repositioning of CGP-60474 as a Highly Potent Anti-Endotoxemic Agent

Scientific Reports
Multidisciplinary
2018English

Serum Anti-Eif3a Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy